Your browser doesn't support javascript.
loading
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats.
Laskowski, Igor A; Pratschke, Johann; Wilhelm, Markus J; Dong, Victor M; Beato, Francisca; Taal, Maarten; Gasser, Martin; Hancock, Wayne W; Sayegh, Mohamed H; Tilney, Nicholas L.
Afiliação
  • Laskowski IA; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Pratschke J; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Wilhelm MJ; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Dong VM; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Beato F; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Taal M; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Gasser M; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Hancock WW; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Sayegh MH; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Tilney NL; *Surgical Research Laboratory, Harvard Medical School Cambridge, Massachusetts; Departments of Surgery and Medicine, Renal Division, Brigham & Women's Hospital, Boston, Massachusetts; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
J Am Soc Nephrol ; 13(2): 519-527, 2002 Feb.
Article em En | MEDLINE | ID: mdl-11805183
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Antígenos CD28 / Rejeição de Enxerto / Anticorpos Monoclonais Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Antígenos CD28 / Rejeição de Enxerto / Anticorpos Monoclonais Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2002 Tipo de documento: Article